Indirect Treatment Comparison of Talimogene Laherparepvec Compared with Ipilimumab and Vemurafenib for the Treatment of Patients with Metastatic Melanoma
Crossref DOI link: https://doi.org/10.1007/s12325-016-0313-x
Published Online: 2016-03-15
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Quinn, Casey
Ma, Qiufei
Kudlac, Amber
Palmer, Stephen
Barber, Beth
Zhao, Zhongyun
Funding for this research was provided by:
Amgen